» Articles » PMID: 10831600

Signaling Lymphocytic Activation Molecule (CDw150) is Homophilic but Self-associates with Very Low Affinity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Jun 1
PMID 10831600
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Signaling lymphocytic activating molecule ((SLAM) CDw150) is a glycoprotein that belongs to the CD2 subset of the immunoglobulin superfamily and is expressed on the surface of activated T- and B-cells. It has been proposed that SLAM is homophilic and required for bidirectional signaling during T- and B-cell activation. Previous work has suggested that the affinity of SLAM self-association might be unusually high, undermining the concept that protein interactions mediating transient cell-cell contacts, such as those involving leukocytes, have to be weak in order that such contacts are readily reversible. Using surface plasmon resonance-based methods and analytical ultracentrifugation (AUC), we confirm that SLAM is homophilic. However, we also establish a new theoretical treatment of surface plasmon resonance-derived homophilic binding data, which indicates that SLAM-SLAM interactions (solution K(d) approximately 200 micrometer) are in fact considerably weaker than most other well characterized protein-protein interactions at the cell surface (solution K(d) approximately 0.4-20 micrometer), a conclusion that is supported by the AUC analysis. Whereas further analysis of the AUC data imply that SLAM could form "head to head" dimers spanning adjacent cells, the very low affinity raises important questions regarding the physiological role and/or properties of such interactions.

Citing Articles

CD150‑dependent activation of EBV‑transformed B cells induces the differentiation of peripheral blood monocytes via the secretion of multiple cytokines.

Kim H, Seo I, Hur D Int J Mol Med. 2024; 54(3).

PMID: 39027993 PMC: 11265835. DOI: 10.3892/ijmm.2024.5403.


SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders.

Kloc D, Kurhajec S, Huniadi M, Sykora J, Guman T, Sarissky M Int J Mol Sci. 2024; 25(7).

PMID: 38612827 PMC: 11012012. DOI: 10.3390/ijms25074014.


SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.

Farhangnia P, Ghomi S, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi A Front Immunol. 2023; 14:1174138.

PMID: 37251372 PMC: 10213746. DOI: 10.3389/fimmu.2023.1174138.


SLAMs Negatively Regulate IL-21 Production in Tfh-Like Cells from Allergic Rhinitis Patients.

Yang J, Geng L, Ma Y, Tang X, Peng H, Tian J J Asthma Allergy. 2021; 14:361-369.

PMID: 33880041 PMC: 8053523. DOI: 10.2147/JAA.S291879.


Signalling lymphocyte activation molecule family member 9 is found on select subsets of antigen-presenting cells and promotes resistance to Salmonella infection.

Wilson T, Clare S, Mikulin J, Johnson C, Harcourt K, Lyons P Immunology. 2019; 159(4):393-403.

PMID: 31880316 PMC: 7078004. DOI: 10.1111/imm.13169.